Promising Nonalcoholic Steatohepatitis Therapies such as AZD2693, Saroglitazar Magnesium 4 mg, Semaglutide (SEMA), Cilofexor ...

NASH is now the number one cause of liver transplants for people under 50 in the US. As fat builds up in the liver, it triggers a cycle of chronic inflammation and fibrosis, which, left unchecked ...

Janus kinase (JAK) inhibitors are an important treatment option for people with chronic inflammatory diseases such as ...

In just 25 minutes, you can whip up one of these tasty anti-inflammatory dinners, from a veggie-packed salad to a plate of creamy pasta. Whatever you choose will include plenty of nutrient-dense ...

Inventiva’s lanifibranor has been tipped to become a blockbuster in the fatty liver disease non-alcoholic steatohepatitis (NASH ... endpoints relating to inflammation resolution and fibrosis ...

This mechanism links TGFβ release in SARS-CoV-2 infection to multisystem inflammatory syndrome in children, and could inform the development of therapies for managing this serious condition.

Hepatocytes, as the most abundant cell type in liver, are a potent source of fibrogenic lipid peroxides in inflammatory liver diseases. Platelets are a potent source of growth factors, and are ...

PPARα is less expressed in the liver of patients with non-alcoholic fatty liver diseases (NAFLD). Several PPAR-targeting molecules, including dual agonists, are currently under investigation for NAFLD ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.